Cargando…
NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2
The Ras oncoprotein is a key driver of cancer. However, Ras also provokes senescence, which serves as a major barrier to Ras-driven transformation. Ras senescence pathways remain poorly characterized. NORE1A is a novel Ras effector that serves as a tumor suppressor. It is frequently inactivated in t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362463/ https://www.ncbi.nlm.nih.gov/pubmed/25778922 http://dx.doi.org/10.1083/jcb.201408087 |
_version_ | 1782361815328489472 |
---|---|
author | Donninger, Howard Calvisi, Diego F. Barnoud, Thibaut Clark, Jennifer Schmidt, M. Lee Vos, Michele D. Clark, Geoffrey J. |
author_facet | Donninger, Howard Calvisi, Diego F. Barnoud, Thibaut Clark, Jennifer Schmidt, M. Lee Vos, Michele D. Clark, Geoffrey J. |
author_sort | Donninger, Howard |
collection | PubMed |
description | The Ras oncoprotein is a key driver of cancer. However, Ras also provokes senescence, which serves as a major barrier to Ras-driven transformation. Ras senescence pathways remain poorly characterized. NORE1A is a novel Ras effector that serves as a tumor suppressor. It is frequently inactivated in tumors. We show that NORE1A is a powerful Ras senescence effector and that down-regulation of NORE1A suppresses senescence induction by Ras and enhances Ras transformation. We show that Ras induces the formation of a complex between NORE1A and the kinase HIPK2, enhancing HIPK2 association with p53. HIPK2 is a tumor suppressor that can induce either proapoptotic or prosenescent posttranslational modifications of p53. NORE1A acts to suppress its proapoptotic phosphorylation of p53 but enhance its prosenescent acetylation of p53. Thus, we identify a major new Ras signaling pathway that links Ras to the control of specific protein acetylation and show how NORE1A allows Ras to qualitatively modify p53 function to promote senescence. |
format | Online Article Text |
id | pubmed-4362463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43624632015-09-16 NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2 Donninger, Howard Calvisi, Diego F. Barnoud, Thibaut Clark, Jennifer Schmidt, M. Lee Vos, Michele D. Clark, Geoffrey J. J Cell Biol Research Articles The Ras oncoprotein is a key driver of cancer. However, Ras also provokes senescence, which serves as a major barrier to Ras-driven transformation. Ras senescence pathways remain poorly characterized. NORE1A is a novel Ras effector that serves as a tumor suppressor. It is frequently inactivated in tumors. We show that NORE1A is a powerful Ras senescence effector and that down-regulation of NORE1A suppresses senescence induction by Ras and enhances Ras transformation. We show that Ras induces the formation of a complex between NORE1A and the kinase HIPK2, enhancing HIPK2 association with p53. HIPK2 is a tumor suppressor that can induce either proapoptotic or prosenescent posttranslational modifications of p53. NORE1A acts to suppress its proapoptotic phosphorylation of p53 but enhance its prosenescent acetylation of p53. Thus, we identify a major new Ras signaling pathway that links Ras to the control of specific protein acetylation and show how NORE1A allows Ras to qualitatively modify p53 function to promote senescence. The Rockefeller University Press 2015-03-16 /pmc/articles/PMC4362463/ /pubmed/25778922 http://dx.doi.org/10.1083/jcb.201408087 Text en © 2015 Donninger et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/). |
spellingShingle | Research Articles Donninger, Howard Calvisi, Diego F. Barnoud, Thibaut Clark, Jennifer Schmidt, M. Lee Vos, Michele D. Clark, Geoffrey J. NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2 |
title | NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2 |
title_full | NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2 |
title_fullStr | NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2 |
title_full_unstemmed | NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2 |
title_short | NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2 |
title_sort | nore1a is a ras senescence effector that controls the apoptotic/senescent balance of p53 via hipk2 |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362463/ https://www.ncbi.nlm.nih.gov/pubmed/25778922 http://dx.doi.org/10.1083/jcb.201408087 |
work_keys_str_mv | AT donningerhoward nore1aisarassenescenceeffectorthatcontrolstheapoptoticsenescentbalanceofp53viahipk2 AT calvisidiegof nore1aisarassenescenceeffectorthatcontrolstheapoptoticsenescentbalanceofp53viahipk2 AT barnoudthibaut nore1aisarassenescenceeffectorthatcontrolstheapoptoticsenescentbalanceofp53viahipk2 AT clarkjennifer nore1aisarassenescenceeffectorthatcontrolstheapoptoticsenescentbalanceofp53viahipk2 AT schmidtmlee nore1aisarassenescenceeffectorthatcontrolstheapoptoticsenescentbalanceofp53viahipk2 AT vosmicheled nore1aisarassenescenceeffectorthatcontrolstheapoptoticsenescentbalanceofp53viahipk2 AT clarkgeoffreyj nore1aisarassenescenceeffectorthatcontrolstheapoptoticsenescentbalanceofp53viahipk2 |